These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12724757)

  • 1. Calcium and heart failure: the cycle game.
    Chien KR; Ross J; Hoshijima M
    Nat Med; 2003 May; 9(5):508-9. PubMed ID: 12724757
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium cycling in heart failure: how the fast became too furious.
    Armand AS; De Windt LJ
    Cardiovasc Res; 2004 Jun; 62(3):439-41. PubMed ID: 15158133
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure].
    Minamisawa S; Ikeda Y
    Clin Calcium; 2006 Jan; 16(1):37-44. PubMed ID: 16397349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
    Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the calcium ATPase with phospholamban and sarcolipin: structure, physiology and pathophysiology.
    Maclennan DH
    J Muscle Res Cell Motil; 2004; 25(8):600-1. PubMed ID: 16118852
    [No Abstract]   [Full Text] [Related]  

  • 7. SERCA upregulation: breaking the positive feedback in heart failure?
    Bassani JW; Bassani RA
    Cardiovasc Res; 2005 Sep; 67(4):581-2. PubMed ID: 16018992
    [No Abstract]   [Full Text] [Related]  

  • 8. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting protein phosphatase 1 in heart failure.
    Champion HC
    Circ Res; 2005 Apr; 96(7):708-10. PubMed ID: 15831821
    [No Abstract]   [Full Text] [Related]  

  • 10. Something old, something new: changing views on the cellular mechanisms of heart failure.
    Sipido KR; Eisner D
    Cardiovasc Res; 2005 Nov; 68(2):167-74. PubMed ID: 16202399
    [No Abstract]   [Full Text] [Related]  

  • 11. Local CA(2+) release in heart failure: timing is important.
    Sipido KR
    Circ Res; 2000 Nov; 87(11):966-8. PubMed ID: 11090539
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorcin interacts with sarcoplasmic reticulum Ca(2+)-ATPase and modulates excitation-contraction coupling in the heart.
    Matsumoto T; Hisamatsu Y; Ohkusa T; Inoue N; Sato T; Suzuki S; Ikeda Y; Matsuzaki M
    Basic Res Cardiol; 2005 May; 100(3):250-62. PubMed ID: 15754088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
    Haghighi K; Gregory KN; Kranias EG
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1214-22. PubMed ID: 15336969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
    Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
    Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment.
    Sabbah HN; Sharov VG; Gupta RC; Mishra S; Rastogi S; Undrovinas AI; Chaudhry PA; Todor A; Mishima T; Tanhehco EJ; Suzuki G
    Circ Res; 2003 Nov; 93(11):1095-101. PubMed ID: 14563716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluating sarcoplasmic reticulum function in heart failure.
    Delling U; Sussman MA; Molkentin JD
    Nat Med; 2000 Sep; 6(9):942-3. PubMed ID: 10973288
    [No Abstract]   [Full Text] [Related]  

  • 18. Phospholamban: a crucial regulator of cardiac contractility.
    MacLennan DH; Kranias EG
    Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.
    Mattiazzi A; Mundiña-Weilenmann C; Guoxiang C; Vittone L; Kranias E
    Cardiovasc Res; 2005 Dec; 68(3):366-75. PubMed ID: 16226237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.